Literature DB >> 20860425

Variable suppression of serum thyroxine in female mice of different inbred strains by triiodothyronine administered in drinking water.

Sepehr Hamidi1, Holly Aliesky, Chun-Rong Chen, Basil Rapoport, Sandra M McLachlan.   

Abstract

BACKGROUND: Recombinant-inbred mouse strains differ in their susceptibility to Graves'-like hyperthyroidism induced by immunization with adenovirus expressing the human thyrotropin (TSH) receptor. Because one genetic component contributing to this susceptibility is altered thyroid sensitivity to TSH receptor agonist stimulation, we wished to quantify thyroid responsiveness to TSH. For such studies, it is necessary to suppress endogenous TSH by administering L-3,5,3′-triiodothyronine (L-T3), with the subsequent decrease in serum thyroxine (T4) reflecting endogenous TSH suppression. Our two objectives were to assess in different inbred strains of mice (i) the extent of serum T4 suppression after L-T3 administration and (ii) the magnitude of serum T4 increase induced by TSH.
METHODS: Mice were tail-bled to establish baseline-serum T4 before L-T3 administration. We initially employed a protocol of L-T3-supplemented drinking water for 7 days. In subsequent experiments, we injected L-T3 intraperitoneally (i.p.) daily for 3 days. Mice were then injected i.p. with bovine TSH (10 mU) and euthanized 5 hours later. Serum T4 was assayed before L-T3 administration, and before and after TSH injection. In some experiments, serum T3 and estradiol were measured in pooled sera.
RESULTS: Oral L-T3 (3 or 5 µg/mL) suppressed serum T4 levels by 26%-64% in female BALB/c mice but >95% in males. T4 suppression in female B6 mice ranged from 0% to 90%. In C3H mice, L-T3 at 3 µg/mL was ineffective but 5 µg/mL achieved >80% serum T4 reduction. Unlike inbred mice, in outbred CF1 mice the same protocol was more effective: 83% in females and 100% suppression in males. The degree of T4 suppression was unrelated to baseline T4, T3, or estradiol, but was related to mouse weight and postmortem T3, with greater suppression in larger mice (outbred CF1 animals and inbred males). Among females with serum T4 suppression >80%, the increase in serum T4 after TSH injection was greater for BALB/c and C3H versus B6 mice. Moreover, the T4 increment was higher in female than in male BALB/c.
CONCLUSIONS: Our data provide important, practical information for future in vivo studies in inbred mice: we recommend that responses to TSH be performed in female animals injected with L-T3 i.p. to suppress baseline T4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860425      PMCID: PMC2947419          DOI: 10.1089/thy.2010.0117

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

1.  Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone.

Authors:  J Pohlenz; A Maqueem; K Cua; R E Weiss; J Van Sande; S Refetoff
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

2.  A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.

Authors:  Yuji Nagayama; Masako Kita-Furuyama; Takao Ando; Kazuhiko Nakao; Hiroyuki Mizuguchi; Takao Hayakawa; Katsumi Eguchi; Masami Niwa
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

3.  Sex steroids modulate the pituitary parameters involved in the regulation of TSH secretion in the rat.

Authors:  A Donda; F Reymond; F Rey; T Lemarchand-Béraud
Journal:  Acta Endocrinol (Copenh)       Date:  1990-05

4.  Susceptibility rather than resistance to hyperthyroidism is dominant in a thyrotropin receptor adenovirus-induced animal model of Graves' disease as revealed by BALB/c-C57BL/6 hybrid mice.

Authors:  Chun-Rong Chen; H Aliesky; P N Pichurin; Y Nagayama; S M McLachlan; B Rapoport
Journal:  Endocrinology       Date:  2004-07-29       Impact factor: 4.736

5.  Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.

Authors:  Alexander Misharin; Martin Hewison; Chun-Rong Chen; Venu Lagishetty; Holly A Aliesky; Yumiko Mizutori; Basil Rapoport; Sandra M McLachlan
Journal:  Endocrinology       Date:  2008-10-16       Impact factor: 4.736

6.  The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim.

Authors:  Chun-Rong Chen; Pavel Pichurin; Yuji Nagayama; Francesco Latrofa; Basil Rapoport; Sandra M McLachlan
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

7.  Effect of 3,5,3'-Triiodothyronine (T3) administration on dio1 gene expression and T3 metabolism in normal and type 1 deiodinase-deficient mice.

Authors:  A L Maia; J D Kieffer; J W Harney; P R Larsen
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

8.  A novel, nonradioactive in vivo bioassay of thyrotropin (TSH).

Authors:  J East-Palmer; M W Szkudlinski; J Lee; N R Thotakura; B D Weintraub
Journal:  Thyroid       Date:  1995-02       Impact factor: 6.568

9.  Hypothyroidism in thyroid transcription factor 1 haploinsufficiency is caused by reduced expression of the thyroid-stimulating hormone receptor.

Authors:  Lars C Moeller; Shioko Kimura; Takashi Kusakabe; Xiao-Hui Liao; Jacqueline Van Sande; Samuel Refetoff
Journal:  Mol Endocrinol       Date:  2003-08-07

10.  Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice.

Authors:  B Rapoport; R W Williams; C-R Chen; S M McLachlan
Journal:  Genes Immun       Date:  2010-04       Impact factor: 2.676

View more
  7 in total

1.  An attempt to induce "Graves' disease of the gonads" by immunizing mice with the luteinizing hormone receptor provides insight into breaking tolerance to self-antigens.

Authors:  Chun-Rong Chen; Holly A Aliesky; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2011-06-07       Impact factor: 6.568

2.  The Circadian Clock Gene Bmal1 Controls Thyroid Hormone-Mediated Spectral Identity and Cone Photoreceptor Function.

Authors:  Onkar B Sawant; Amanda M Horton; Olivia F Zucaro; Ricky Chan; Vera L Bonilha; Ivy S Samuels; Sujata Rao
Journal:  Cell Rep       Date:  2017-10-17       Impact factor: 9.423

3.  Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease.

Authors:  Andréa V Maglione; Bruna P P do Nascimento; Miriam O Ribeiro; Talytha J L de Souza; Renata E C da Silva; Monica A Sato; Carlos A A Penatti; Luiz R G Britto; Janaina S de Souza; Rui M B Maciel; Rodrigo Rodrigues da Conceição; Roberto Laureano-Melo; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2022-08-11       Impact factor: 3.655

4.  Genetic linkages for thyroxine released in response to thyrotropin stimulation in three sets of recombinant inbred mice provide evidence for shared and novel genes controlling thyroid function.

Authors:  Sepehr Hamidi; Holly A Aliesky; Robert W Williams; Basil Rapoport; Sandra M McLachlan
Journal:  Thyroid       Date:  2013-03       Impact factor: 6.568

5.  A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.

Authors:  Susanne Neumann; Eshel A Nir; Elena Eliseeva; Wenwei Huang; Juan Marugan; Jingbo Xiao; Andrés E Dulcey; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2013-12-04       Impact factor: 4.736

6.  Synthetic gene network restoring endogenous pituitary-thyroid feedback control in experimental Graves' disease.

Authors:  Pratik Saxena; Ghislaine Charpin-El Hamri; Marc Folcher; Henryk Zulewski; Martin Fussenegger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

Review 7.  Sustained Release T3 Therapy: Animal Models and Translational Applications.

Authors:  Thaer Idrees; John D Price; Thomas Piccariello; Antonio C Bianco
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-13       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.